FFRangio System vs TruPlan
AI Verdict
Choose FFRangio System if…
Choose the FFRangio System if your cardiology department requires real-time, wire-free, and drug-free functional assessment of coronary artery disease to optimize percutaneous coronary intervention (PCI) decisions. This tool is ideal for quickly obtaining multi-vessel FFR results and advanced insights, such as lesion impact and simulated pullback curves, directly within the cath lab to confirm treatment effectiveness.
View FFRangio System →Choose TruPlan if…
Choose TruPlan if your institution performs Left Atrial Appendage Closure (LAAC) procedures and needs comprehensive AI-enabled CT imaging software for pre-procedural planning and post-procedural follow-up. It is particularly well-suited for detailed 3D anatomical assessment, automated LAA landing zone definition, and simulation of various imaging views (TEE, ICE, fluoroscopic) to ensure precise device selection and placement.
View TruPlan →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | FFRangio System | TruPlan |
|---|---|---|
| Pricing | Contact vendor for pricing information. | Unknown |
| Deployment | SaaS, on-prem, hybrid | Standalone software on desktop/laptop or server within hospital infrastructure with thick-client software on multiple desktops/laptops. It runs locally without an internet connection, though license key activation requires a direct internet connection. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
FFRangio SystemTool A emphasizes an 'intuitive user interface' and 'seamless integration with cath lab boom and PACS', suggesting a highly streamlined workflow in a real-time procedural environment where ease of use is critical. While Tool B offers advanced visualization, Tool A's focus on integrated, real-time operation within the cath lab gives it an edge in practical usability for its specific application.
Clinical Value
FFRangio SystemBoth tools offer significant clinical value in their respective domains with FDA clearance. However, Tool A's 'wire-free and drug-free' approach to FFR guidance directly reduces invasiveness and eliminates the need for pressure wires and hyperemic agents, offering a less risky and more efficient diagnostic process during PCI.
Pricing & Value
TruPlanWhile both require contacting for pricing, Tool B explicitly states it 'may be accessible at no additional cost through Boston Scientific representatives' for WATCHMAN procedures, offering a clear potential pathway to significant cost savings for specific users. Tool A only provides a general 'contact for pricing' statement.
Enterprise Readiness
TruPlanTool B explicitly confirms HIPAA compliance and the presence of a Business Associate Agreement (BAA), which are crucial for healthcare enterprise adoption and data security. Tool A states BAA is 'likely' and HIPAA compliance is 'unknown,' despite being ISO 27001 certified.
Innovation
FFRangio SystemTool A's 'wire-free and drug-free 3D FFR guidance' represents a significant paradigm shift by eliminating invasive pressure wires and pharmacological stress agents for FFR assessment. This fundamentally changes the approach to coronary physiology assessment, offering a less invasive and potentially more efficient method.
Support & Docs
TieTool A's information does not explicitly detail its support or documentation offerings, though it does offer an 'Instructions For Use (IFU)' upon request. Tool B's parent company, Circle CVI, mentions general 'Customer Support' and provides access to various documentation like 'User Manual' and 'Installation Guide' for TruPlan. However, without specific details on the quality or accessibility of support for either, it is difficult to definitively pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | FFRangio System | TruPlan |
|---|---|---|
| Product Name | FFRangio System | TruPlan |
| Company | CathWorks | Circle Cardiovascular Imaging |
| Primary Application | Wire-free and drug-free 3D FFR guidance for optimizing PCI decisions in patients with coronary artery disease. | AI-enabled CT imaging software for comprehensive pre-procedural planning and post-procedural follow-up of Left Atrial Appendage Closure (LAAC) procedures. |
| Key Differentiating Feature (Physiology/Planning) | Delivers real-time FFRangio values at every point on the coronary tree and simulated pullback curve. | Offers AI-enabled Left Heart Segmentation and Automated LAA Landing Zone Definition. |
| Target Condition/Procedure | Coronary Artery Disease (PCI optimization) | Left Atrial Appendage Closure (LAAC) procedures |
Videos
Demos, reviews, and walkthroughs featuring FFRangio System and TruPlan.